The role of radionuclide imaging in epilepsy, part 1: Sporadic temporal and extratemporal lobe epilepsy

Journal of Nuclear Medicine

Volumn 54, Issue 10, 2013, Pages 1775-1781

  Kumar, Ajay ^a   Chugani, Harry T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Epilepsy surgery; Epilepsy syndromes; PET; Radionuclide; SPECT

Indexed keywords

6 FLUORODOPA F 18; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL C 11; ALPHA METHYL LEVO TRYPTOPHAN C 11; CARFENTANIL C 11; CYCLOFOXY F 18; CYSTEINE ETHYL ESTER TC 99M; DEUTERIUM DEPRENYL C 11; DIPRENORPHINE C 11; DOXEPIN C 11; FALLYPRIDE F 18; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; KETAMINE C 11; METHYLNALTRINDOLE C 11; N ACETYL N (2 METHOXYBENZYL) 2 PHENOXY 5 PYRIDINAMINE C 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; TRACER; UNCLASSIFIED DRUG; WATER O 15; RADIOISOTOPE;

ARTICLE; BRAIN SURGERY; DIAGNOSTIC ERROR; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC FOCUS; EXTRATEMPORAL LOBE EPILEPSY; FRONTAL LOBE EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; PROCEDURES; SCINTISCANNING; 18F-FDG; EPILEPSY SURGERY; EPILEPSY SYNDROMES; METHODOLOGY; PET; REVIEW;

EPILEPSY, TEMPORAL LOBE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

18F-FDG; EPILEPSY; EPILEPSY SURGERY; EPILEPSY SYNDROMES; PET; RADIONUCLIDE; SPECT;

EID: 84891666714     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.114397     Document Type: Article

References (78)

1. Rocher AB, Chapon F, Blaizot X, Baron JC, Chavoix C. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 2003;20:1894-1898.
2. 18FDGPET in children with new-onset partial epilepsy: a prospective study. Neurology. 2002;58:717-722.
3. Benedek K, Juhasz C, Chugani DC, Muzik O, Chugani HT. Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol. 2006;21:26-31.
4. Theodore WH. Antiepileptic drugs and cerebral glucose metabolism. Epilepsia. 1988;29(suppl 2):S48-S55.
5. Muzik O, Chugani DC, Shen C, et al. Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci. Comput Aided Surg. 1998;3:74-82.
6. 18F-FDG PET using SPM. Seizure. 2006;15:56-63.
7. 18F-FDG PET in children undergoing epilepsy surgery. J Nucl Med. 2010;51:1901-1907.
8. Van Bogaert P, Massager N, Tugendhaft P, et al. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage. 2000;12:129-138.
9. 11C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies. Biomark Med. 2011;5: 577-584.
10. Hougaard K, Oikawa T, Sveinsdottir E, Skinoj E, Ingvar DH, Lassen NA. Regional cerebral blood flow in focal cortical epilepsy. Arch Neurol. 1976;33:527-535.
11. Prince DA, Wilder BJ. Control mechanisms in cortical epileptogenic foci: "surround" inhibition. Arch Neurol. 1967;16:194-202.
12. Bruggemann JM, Som SS, Lawson JA, Haindl W, Cunningham AM, Bye AM. Application of statistical parametric mapping to SPET in the assessment of intractable childhood epilepsy. Eur J Nucl Med Mol Imaging. 2004;31:369-377.
13. Lee JD, Kim HJ, Lee BI, Kim OJ, Jeon TJ, Kim MJ. Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy. Eur J Nucl Med. 2000;27:1658-1665.
14. O'Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology. 1998;50:445-454.
15. Chiron C, Vera P, Kaminska A, et al. Single-photon emission computed tomography: ictal perfusion in childhood epilepsies. Brain Dev. 1999;21:444-446.
16. O'Brien TJ, So EL, Mullan BP, et al. Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome. Neurology. 2000;55:1668-1677.
17. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH. FDGPET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology. 1995;45:123-126.
18. Knowlton RC, Laxer KD, Ende G, et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol. 1997; 42:829-837.
19. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy: a prospective study in 100 patients. Brain. 1998;121:2067-2081.
20. Theodore WH, Sato S, Kufta CV, Gaillard WD, Kelley K. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia. 1997;38:81-86.
21. 18F-FDG positron emission tomography. Neurology. 1993;43:79-86.
22. 18FFDG PET using SPM. J Nucl Med. 2003;44:1006-1012.
23. Henry TR, Mazziotta JC, Engel J Jr. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol. 1993;50:582-589.
24. Chassoux F, Semah F, Bouilleret V, et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. Brain. 2004;127: 164-174.
25. da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia. 1997;38: 1198-1208.
26. 18F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002;43:1167-1174.
27. 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy. Epilepsia. 1995;36:388-395.
28. Patil S, Biassoni L, Borgwardt L. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med. 2007;37:357-381.
29. Ollenberger GP, Byrne AJ, Berlangieri SU, et al. Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy. Eur J Nucl Med Mol Imaging. 2005;32:1311-1316.
30. 18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia. 2007;48:2121-2129.
31. 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy: a meta-analysis. Seizure. 2007;16:509-520.
32. Knowlton RC, Elgavish RA, Bartolucci A, et al. Functional imaging: II. Prediction of epilepsy surgery outcome. Ann Neurol. 2008;64:35-41.
33. Uijl SG, Leijten FS, Arends JB, Parra J, van Huffelen AC, Moons KG. Prognosis after temporal lobe epilepsy surgery: the value of combining predictors. Epilepsia. 2008;49:1317-1323.
34. Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol. 1992;32:789-794.
35. Kim DW, Lee SK, Chu K, et al. Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia. Neurology. 2009;72:211-216.
36. 18FDG-positron emission tomography. Invest Radiol. 1996;31:261-266.
37. Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology. 1994;44:2331-2336.
38. Wong CH, Bleasel A, Wen L, et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia. 2010;51:1365-1373.
39. Koutroumanidis M, Hennessy MJ, Seed PT, et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology. 2000;54: 1811-1821.
40. Jokeit H, Seitz RJ, Markowitsch HJ, Neumann N, Witte OW, Ebner A. Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy. Brain. 1997;120:2283-2294.
41. Bouilleret V, Dupont S, Spelle L, Baulac M, Samson Y, Semah F. Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol. 2002;51:202-208.
42. Juhász C, Behen ME, Muzik O, Chugani DC, Chugani HT. Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression. Epilepsia. 2001;42:991-1001.
43. Newberg AB, Alavi A, Berlin J, Mozley PD, O'Connor M, Sperling M. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. J Nucl Med. 2000;41:1964-1968.
44. 18F] FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry. 1993;56: 615-621.
45. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain. 1996;119:1677-1687.
46. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 1993;43:1998-2006.
47. 11Cflumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology. 2000;54:332-339.
48. Muzik O, da Silva EA, Juhasz C, et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology. 2000;54: 171-179.
49. 11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia. 1995;36:1225-1232.
50. Juhász C, Chugani DC, Muzik O, et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology. 2001;56: 1650-1658.
51. Richardson MP, Friston KJ, Sisodiya SM, et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development: a voxel-based comparison of structural and functional imaging data. Brain. 1997;120:1961-1973.
52. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain. 2002;125:2257-2271.
53. 11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology. 2003; 60:756-761.
54. 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia. 2011;52:1692-1698.
55. Frost JJ, Mayberg HS, Fisher RS, et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol. 1988;23:231-237.
56. Mayberg HS, Sadzot B, Meltzer CC, et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 1991;30:3-11.
57. Koepp MJ, Richardson MP, Brooks DJ, Duncan JS. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet. 1998;352:952-955.
58. 3H]-PK 11195 binding sites in human epileptic hippocampus. Epilepsia. 1992;33:610-617.
59. 18F-FDG in focal epilepsy. Acta Neurol Scand. 2001;103: 360-366.
60. 18F]fallypride PET study. Epilepsia. 2006; 47:1392-1396.
61. 11C]verapamil. Epilepsia. 2007;48: 1774-1784.
62. 11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia. 1999;40:30-37.
63. Iinuma K, Yokoyama H, Otsuki T, et al. Histamine H1 receptors in complex partial seizures [letter]. Lancet. 1993;341:238.
64. Fedi M, Berkovic SF, Scheffer IE, et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 2008;71:795-798.
65. Picard F, Bruel D, Servent D, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 2006;129:2047-2060.
66. Hirvonen J, Kreisl WC, Fujita M, et al. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med. 2012;53:234-240.
67. Kaminska A, Chiron C, Ville D, et al. Ictal SPECT in children with epilepsy: comparison with intracranial EEG and relation to postsurgical outcome. Brain. 2003;126:248-260.
68. 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPET. Seizure. 2005;14:213-220.
69. Véra P, Kaminska A, Cieuta C, et al. Use of subtraction ictal SPECT co-registered to MRI for optimizing the localization of seizure foci in children. J Nucl Med. 1999;40:786-792.
70. Benifla M, Otsubo H, Ochi A, et al. Temporal lobe surgery for intractable epilepsy in children: an analysis of outcomes in 126 children. Neurosurgery. 2006;59:1203-1213.
71. 99mTc-HMPAO single photon emission computed tomography in children with temporal lobe epilepsy. Epilepsia. 1993;34:869-877.
72. Rowe CC, Berkovic SF, Austin MC, McKay WJ, Bladin PF. Patterns of postictal cerebral blood flow in temporal lobe epilepsy: qualitative and quantitative analysis. Neurology. 1991;41:1096-1103.
73. Chiron C, Vera P, Kaminska A, et al. Rev Neurol (Paris). 1999;155:477-481.
74. O'Brien TJ, So EL, Mullan BP, et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology. 1999;52:137-146.
75. Weil S, Noachtar S, Arnold S, Yousry TA, Winkler PA, Tatsch K. Ictal ECDSPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control. Nucl Med Commun. 2001;22: 233-237.
76. Seo JH, Holland K, Rose D, et al. Multimodality imaging in the surgical treatment of children with nonlesional epilepsy. Neurology. 2011;76:41-48.
77. Sturm JW, Newton MR, Chinvarun Y, Berlangieri SU, Berkovic SF. Ictal SPECT and interictal PET in the localization of occipital lobe epilepsy. Epilepsia. 2000;41:463-466.
78. 99mTc]-HMPAO SPECT in occipital lobe epilepsy. Epilepsia. 2001;42: 1531-1540.